<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 11 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
h1
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";}
h3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.RegularParagraphs, li.RegularParagraphs, div.RegularParagraphs
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.1Paragraph, li.1Paragraph, div.1Paragraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.1ParagraphContd, li.1ParagraphContd, div.1ParagraphContd
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-indent:-1.0in;
	line-height:200%;
	font-size:12.0pt;
	font-family:"Courier New";}
p.ASubparagraph, li.ASubparagraph, div.ASubparagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	margin-bottom:.0001pt;
	text-indent:-1.5in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.ASubparagraphContd, li.ASubparagraphContd, div.ASubparagraphContd
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	margin-bottom:.0001pt;
	text-indent:-1.5in;
	line-height:200%;
	font-size:12.0pt;
	font-family:"Courier New";}
p.iClause, li.iClause, div.iClause
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-indent:-2.0in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.MeasureTitle, li.MeasureTitle, div.MeasureTitle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:center;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Courier New";
	text-transform:uppercase;}
p.XNotesHeading, li.XNotesHeading, div.XNotesHeading
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";
	font-weight:bold;}
p.XNotes, li.XNotes, div.XNotes
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.Constitution, li.Constitution, div.Constitution
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.aSubsection, li.aSubsection, div.aSubsection
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.Style1, li.Style1, div.Style1
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
 /* Page Definitions */
 @page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.Section1
	{page:Section1;}
-->
</style>

</head>

<body lang=EN-US>

<div class=Section1>

<p class=RegularParagraphs>     <b>§329-14  Schedule I.</b>  (a)  The
controlled substances listed in this section are included in schedule I.</p>

<p class=RegularParagraphs>     (b)  Any of the following opiates, including
their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers,
unless specifically excepted, whenever the existence of these isomers, esters,
ethers, and salts is possible within the specific chemical designation:</p>

<p class=1Paragraph>     (1)  Acetyl-alpha-methylfentanyl
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);</p>

<p class=1Paragraph>     (2)  Acetylmethadol;</p>

<p class=1Paragraph>     (3)  Allylprodine;</p>

<p class=1Paragraph>     (4)  Alphacetylmethadol (except
levo-alphacetylmethadol, levomethadyl acetate, or LAAM);</p>

<p class=1Paragraph>     (5)  Alphameprodine;</p>

<p class=1Paragraph>     (6)  Alphamethadol;</p>

<p class=1Paragraph>     (7)  Alpha-methylfentanyl
(N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide;
1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);</p>

<p class=1Paragraph>     (8)  Alpha-methylthiofentanyl
(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);</p>

<p class=1Paragraph>     (9)  Benzethidine;</p>

<p class=1Paragraph>    (10)  Betacetylmethadol;</p>

<p class=1Paragraph>    (11)  Beta-hydroxyfentanyl
(N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide;</p>

<p class=1Paragraph>    (12)  Beta-hydroxy-3-methylfentanyl (N-[1-(2-
hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);</p>

<p class=1Paragraph>    (13)  Betameprodine;</p>

<p class=1Paragraph>    (14)  Betamethadol;</p>

<p class=1Paragraph>    (15)  Betaprodine;</p>

<p class=1Paragraph>    (16)  Clonitazene;</p>

<p class=1Paragraph>    (17)  Dextromoramide;</p>

<p class=1Paragraph>    (18)  Diampromide;</p>

<p class=1Paragraph>    (19)  Diethylthiambutene;</p>

<p class=1Paragraph>    (20)  Difenoxin;</p>

<p class=1Paragraph>    (21)  Dimenoxadol;</p>

<p class=1Paragraph>    (22)  Dimepheptanol;</p>

<p class=1Paragraph>    (23)  Dimethylthiambutene;</p>

<p class=1Paragraph>    (24)  Dioxaphetyl butyrate;</p>

<p class=1Paragraph>    (25)  Dipipanone;</p>

<p class=1Paragraph>    (26)  Ethylmethylthiambutene;</p>

<p class=1Paragraph>    (27)  Etonitazene;</p>

<p class=1Paragraph>    (28)  Etoxeridine;</p>

<p class=1Paragraph>    (29)  Furethidine;</p>

<p class=1Paragraph>    (30)  Hydroxypethidine;</p>

<p class=1Paragraph>    (31)  Ketobemidone;</p>

<p class=1Paragraph>    (32)  Levomoramide;</p>

<p class=1Paragraph>    (33)  Levophenacylmorphan;</p>

<p class=1Paragraph>    (34)  3-Methylfentanyl
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);</p>

<p class=1Paragraph>    (35)  3-methylthiofentanyl
(N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);</p>

<p class=1Paragraph>    (36)  Morpheridine;</p>

<p class=1Paragraph>    (37)  MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);</p>

<p class=1Paragraph>    (38)  Noracymethadol;</p>

<p class=1Paragraph>    (39)  Norlevorphanol;</p>

<p class=1Paragraph>    (40)  Normethadone;</p>

<p class=1Paragraph>    (41)  Norpipanone;</p>

<p class=1Paragraph>    (42)  Para-fluorofentanyl
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide;</p>

<p class=1Paragraph>    (43)  PEPAP
(1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine;</p>

<p class=1Paragraph>    (44)  Phenadoxone;</p>

<p class=1Paragraph>    (45)  Phenampromide;</p>

<p class=1Paragraph>    (46)  Phenomorphan;</p>

<p class=1Paragraph>    (47)  Phenoperidine;</p>

<p class=1Paragraph>    (48)  Piritramide;</p>

<p class=1Paragraph>    (49)  Proheptazine;</p>

<p class=1Paragraph>    (50)  Properidine;</p>

<p class=1Paragraph>    (51)  Propiram;</p>

<p class=1Paragraph>    (52)  Racemoramide;</p>

<p class=1Paragraph>    (53)  Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);</p>

<p class=1Paragraph>    (54)  Tilidine;</p>

<p class=1Paragraph>    (55)  Trimeperidine;</p>

<p class=1Paragraph>    (56)  N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
(benzylfentanyl), its optical isomers, salts, and salts of isomers; and</p>

<p class=1Paragraph>    (57)  N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
(thenylfentanyl), its optical isomers, salts, and salts of isomers.</p>

<p class=RegularParagraphs>     (c)  Any of the following opium derivatives,
their salts, isomers, and salts of isomers, unless specifically excepted,
whenever the existence of these salts, isomers, and salts of isomers is
possible within the specific chemical designation:</p>

<p class=1Paragraph>     (1)  Acetorphine;</p>

<p class=1Paragraph>     (2)  Acetyldihydrocodeine;</p>

<p class=1Paragraph>     (3)  Benzylmorphine;</p>

<p class=1Paragraph>     (4)  Codeine methylbromide;</p>

<p class=1Paragraph>     (5)  Codeine-N-Oxide;</p>

<p class=1Paragraph>     (6)  Cyprenorphine;</p>

<p class=1Paragraph>     (7)  Desomorphine;</p>

<p class=1Paragraph>     (8)  Dihydromorphine;</p>

<p class=1Paragraph>     (9)  Drotebanol;</p>

<p class=1Paragraph>    (10)  Etorphine;</p>

<p class=1Paragraph>    (11)  Heroin;</p>

<p class=1Paragraph>    (12)  Hydromorphinol;</p>

<p class=1Paragraph>    (13)  Methyldesorphine;</p>

<p class=1Paragraph>    (14)  Methyldihydromorphine;</p>

<p class=1Paragraph>    (15)  Morphine methylbromide;</p>

<p class=1Paragraph>    (16)  Morphine methylsulfonate;</p>

<p class=1Paragraph>    (17)  Morphine-N-Oxide;</p>

<p class=1Paragraph>    (18)  Myrophine;</p>

<p class=1Paragraph>    (19)  Nicocodeine;</p>

<p class=1Paragraph>    (20)  Nicomorphine;</p>

<p class=1Paragraph>    (21)  Normorphine;</p>

<p class=1Paragraph>    (22)  Phoclodine;</p>

<p class=1Paragraph>    (23)  Thebacon.</p>

<p class=RegularParagraphs>     (d)  Any material, compound, mixture, or
preparation that contains any quantity of the following hallucinogenic
substances, their salts, isomers, and salts of isomers, unless specifically
excepted, whenever the existence of these salts, isomers, and salts of isomers
is possible within the specific chemical designation:</p>

<p class=1Paragraph>     (1)  Alpha-ethyltryptamine (AET);</p>

<p class=1Paragraph>     (2)  2,5-dimethoxy-4-ethylamphetamine (DOET);</p>

<p class=1Paragraph>     (3)  2,5-dimethoxyamphetamine (2,5-DMA);</p>

<p class=1Paragraph>     (4)  3,4-methylenedioxy amphetamine;</p>

<p class=1Paragraph>     (5)  3,4-methylenedioxymethamphetamine (MDMA);</p>

<p class=1Paragraph>     (6)  N-hydroxy-3,4-methylenedioxyamphetamine
(N-hydroxy-MDA);</p>

<p class=1Paragraph>     (7)  3,4-methylenedioxy-N-ethylamphetamine (MDE);</p>

<p class=1Paragraph>     (8)  5-methoxy-3,4-methylenedioxy-amphetamine;</p>

<p class=1Paragraph>     (9)  4-bromo-2,5-dimethoxy-amphetamine(4-bromo-2,5-DMA);</p>

<p class=1Paragraph>    (10)  4-Bromo-2,5-dimethoxyphenethylamine (Nexus);</p>

<p class=1Paragraph>    (11)  3,4,5-trimethoxy amphetamine;</p>

<p class=1Paragraph>    (12)  Bufotenine;</p>

<p class=1Paragraph>    (13)  4-methoxyamphetamine (PMA);</p>

<p class=1Paragraph>    (14)  Diethyltryptamine;</p>

<p class=1Paragraph>    (15)  Dimethyltryptamine;</p>

<p class=1Paragraph>    (16)  4-methyl-2,5-dimethoxy-amphetamine;</p>

<p class=1Paragraph>    (17)  Gamma hydroxybutyrate (GHB) (some other names
include gamma hydroxybutyric acid; 4-hydroxybutyrate; 4-hydroxybutanoic acid;
sodium oxybate; sodium oxybutyrate);</p>

<p class=1Paragraph>    (18)  Ibogaine;</p>

<p class=1Paragraph>    (19)  Lysergic acid diethylamide;</p>

<p class=1Paragraph>    (20)  Marijuana;</p>

<p class=1Paragraph>    (21)  Parahexyl;</p>

<p class=1Paragraph>    (22)  Mescaline;</p>

<p class=1Paragraph>    (23)  Peyote;</p>

<p class=1Paragraph>    (24)  N-ethyl-3-piperidyl benzilate;</p>

<p class=1Paragraph>    (25)  N-methyl-3-piperidyl benzilate;</p>

<p class=1Paragraph>    (26)  Psilocybin;</p>

<p class=1Paragraph>    (27)  Psilocyn;</p>

<p class=1Paragraph>    (28)  1-[1-(2-Thienyl) cyclohexyl] Pyrrolidine (TCPy);</p>

<p class=1Paragraph>    (29)  Tetrahydrocannabinols;</p>

<p class=1Paragraph>    (30)  Ethylamine analog of phencyclidine (PCE);</p>

<p class=1Paragraph>    (31)  Pyrrolidine analog of phencyclidine (PCPy, PHP);</p>

<p class=1Paragraph>    (32)  Thiophene analog of phencyclidine (TPCP; TCP);</p>

<p class=1Paragraph>    (33)  Gamma-butyrolactone, including butyrolactone;
butyrolactone gamma; 4-butyrolactone; 2(3H)-furanone dihydro;
dihydro-2(3H)-furanone; tetrahydro-2-furanone; 1,2-butanolide; 1,4-butanolide;
4-butanolide; gamma-hydroxybutyric acid lactone; 3-hydroxybutyric acid lactone
and 4-hydroxybutanoic acid lactone with Chemical Abstract Service number
96-48-0 when any such substance is intended for human ingestion; </p>

<p class=1Paragraph>    (34)  1,4 butanediol, including butanediol;
butane-1,4-diol; 1,4- butylenes glycol; butylene glycol; 1,4-dihydroxybutane;
1,4- tetramethylene glycol; tetramethylene glycol; tetramethylene 1,4- diol
with Chemical Abstract Service number 110-63-4 when any such substance is
intended for human ingestion;</p>

<p class=1Paragraph>    (35)  2,5-dimethoxy-4-(n)-propylthiophenethylamine
(2C-T-7), its optical isomers, salts, and salts of isomers; </p>

<p class=1Paragraph>    (36)  N-benzylpiperazine (BZP; 1-benzylpiperazine) its
optical isomers, salts, and salts of isomers;</p>

<p class=1Paragraph>    (37)  1-(3-trifluoromethylphenyl)piperazine (TFMPP),
its optical isomers, salts, and salts of isomers;</p>

<p class=1Paragraph>    (38)  Alpha-methyltryptamine (AMT), its isomers, salts,
and salts of isomers; and</p>

<p class=1Paragraph>    (39)  5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT),
its isomers, salts, and salts of isomers.</p>

<p class=RegularParagraphs>     (e)  Unless specifically excepted, the schedule
shall include any material, compound, mixture, or preparation which contains
any quantity of the substance:</p>

<p class=1Paragraph>     (1)  Mecloqualone;</p>

<p class=1Paragraph>     (2)  Methaqualone.</p>

<p class=RegularParagraphs>     (f)  Stimulants.  Unless specifically excepted
or unless listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances having a
stimulant effect on the central nervous system, including its salts, isomers,
and salts of isomers:</p>

<p class=1Paragraph>     (1)  Aminorex;</p>

<p class=1Paragraph>     (2)  Cathinone;</p>

<p class=1Paragraph>     (3)  Fenethylline;</p>

<p class=1Paragraph>     (4)  Methcathinone;</p>

<p class=1Paragraph>     (5)  N-ethylamphetamine;</p>

<p class=1Paragraph>     (6)  4-methylaminorex;</p>

<p class=1Paragraph>     (7)  N,N-dimethylamphetamine. [L 1972, c 10, pt of §1;
am L 1974, c 217, §1; am L 1977, c 116, §1; am L 1978, c 68, §2; am L 1979, c
194, §1; am L 1980, c 140, §1 and c 232, §16; am L 1984, c 166, §1; am L 1985,
c 150, §1; am L 1986, c 214, §§2, 3; am L 1988, c 59, §1; am L 1990, c 138, §3;
am L 1993, c 8, §1; am L 1995, c 122, §1; am L 1997, c 356, §1; am L 1999, c
252, §2; am L 2000, c 98, §1; am L 2001, c 203, §2; am L 2003, c 151, §§1, 2]</p>

<p class=RegularParagraphs>&nbsp;</p>

<p class=XNotesHeading>Case Notes</p>

<p class=XNotes><span style='font-family:Courier'>&nbsp;</span></p>

<p class=XNotes>  Proscription of distribution of lysergic acid
&quot;diethylamine&quot; under this section (1974) cannot be extended by
analogy under §701-104 to distribution of lysergic acid diethylamide.  61 H.
74, 595 P.2d 288.</p>

<p class=XNotes>&nbsp;</p>

</div>

</body>

</html>
<center><table border="0" width="90%"><tr>
<td align="left"><a href="/hrs2007/Vol06_Ch0321-0344/HRS0329/HRS_0329-0013.htm">Previous</a></td>
<td align="center"><a href=/hrs2007/Vol06_Ch0321-0344>Vol06_Ch0321-0344</a></td>
<td align="right"><a href="/hrs2007/Vol06_Ch0321-0344/HRS0329/HRS_0329-0015.htm">Next</a></td>
</tr></table></center>
